Endothelin-1 secreted from keratinocytes stimulates fibroblast-embedded collagen gel contraction in vitro

Nanofiber enabled layer-by-layer approach toward three-dimensional tissue formation

Taking rapid and efficient formation of functional tissues as our long-term goal, we discuss in this study a new and generic approach toward formation of multilayered three-dimensional (3D) tissues using nanofibers. 3:1 poly (epsilon-caprolactone) (PCL) (8% w/v)/collagen (8.0% w/v) solution was electrospun into nanofibers with an average diameter of 454.5 +/- 84.9 nm. The culture of human dermal fibroblasts (NHDF) on PCL/collagen nanofibers showed a high initial cell adhesion (88.1 +/- 1.5%), and rapid cell spreading with spindle morphology. Three-dimensional multilayered cell-nanofiber constructs were built with alternating NHDF seeding (1 x 10(5)cells/layer) and PCL/collagen nanofiber collection on site of electrospinning, where almost all the seeded cells retained in the constructs. The formed construct showed layered structure with uniform cell distribution in between layers of PCL/collagen nanofibers. In the 3D constructs, cells continuously proliferated and deposited new extracellular matrix. By culturing either fibroblast/fiber layered constructs or keratinocyte/fibroblast/fiber layered constructs, dermal-like tissues or bilayer skin tissues (containing both epidermal and dermal layers) were consequently produced within 1 week. Taken together, the present study reports a novel approach to 3D multilayered tissue formation using a bottom-up, on-site layer-by-layer cell assembly while electrospinning. This approach has marked potentials to form functional tissues composed of multiple types of cells, heterogeneous scaffold composition, and customized specific microenvironment for cells.

Prostacyclin analogs inhibit fibroblast contraction of collagen gels through the cAMP-PKA pathway

Prostacyclin is an arachidonic acid metabolite that modulates vascular tone within the lung. The current study evaluated the hypothesis that prostacyclin can also modulate tissue remodeling by affecting fibroblast-mediated contraction of extracellular matrix. To accomplish this, fibroblasts were cultured in three-dimensional native type I collagen gels in the presence of prostacyclin analogs: carbaprostacyclin, iloprost, and beraprost. All three analogs significantly inhibited contraction of the three-dimensional collagen gels mediated by three different fibroblasts. All three analogs significantly inhibited fibronectin release and reduced fibroblast fibronectin mRNA expression. Addition of exogenous fibronectin restored the contractile activity to fibroblasts incubated in the presence of all three analogs. Iloprost and beraprost significantly activated cAMP-dependent protein kinase-A (PKA), and an action through this pathway was confirmed by blockade of the inhibitory effect on contraction and fibronectin release with the PKA inhibitor KT-5720. In contrast, carbaprostacyclin, which is not as selective for the prostacyclin (IP) receptor, did not activate PKA, and its effects on contraction and fibronectin release were not fully blocked by KT-5720. Finally, the cAMP analogs N(6)-Benzoyl- (6-Bnz-) cAMP and dibutyryl-cAMP inhibited contraction, and this contrasted with the activity of an Epac selective agonist 8-pCPT-2'-O-Me-cAMP, which had no effect. Taken together, these results indicate that prostacyclin, acting through the IP receptor and by activating PKA, can lead to inhibition of fibronectin release and can subsequently inhibit fibroblast-mediated collagen gel contraction. The ability of prostacyclin to modulate fibroblast function suggests that prostacyclin can contribute to tissue remodeling.